EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells

Takayuki Nishiwaki, Takumi Yamada, Urara Kudo, Shinsuke Nakamura, Yoshiki Kuse, Kenji Shoda, Tetsuya Yamada, Hiroaki Takei, Yusuke Egashira, Hideaki Hara, Noriyuki Nakayama, Tsuyoshi Izumo und 1 weitere

Cancer Treatment and Research Communications · 2026 · 49 · 101433

DOI: 10.1016/j.ctarc.2026.101433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Takayuki Nishiwaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan; Departme…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: 5-aminolevulinic acid (5-ALA)-mediated photodynamic diagnosis (PDD), a standard surgical adjunct for glioblastoma (GBM), is limited in its efficacy by heterogeneous protoporphyrin IX (PpIX) accumulation. We investigated the drug repurposing potential of griseofulvin (GF), an antifungal agent, as a dual-action agent that directly inhibits tumor growth through cell cycle arrest and enhances 5-ALA-induced fluorescence by regulating ferrochelatase (FECH). METHODS: The antitumor effects of GF on glioma stem-like cells (NCH644) and other differentiated GBM cell lines were evaluated using cell viability, colony formation, and cell cycle assays. PpIX accumulation and its enhancement by GF were quantified using a time-course analysis. The mechanisms were investigated using western blotting, RT-qPCR, and confocal visualization. An orthotopic GBM mouse model was used to assess in vivo antitumor activity using preliminary ex vivo fluorescence imaging. RESULTS: GF first exerted direct antitumor effects via G2/M arrest, characterized by cyclin D1 downregulation and cyclin B1 transient upregulation. Second, GF attenuated the 5-ALA-induced increase in FECH mRNA levels and enhanced PpIX accumulation. In vivo, oral administration of GF significantly inhibited tumor growth in vivo In a preliminary ex vivo assessment, tumors from GF-treated mice showed a higher tumor-to-normal PpIX fluorescence ratio than those receiving 5-ALA monotherapy, enabling superior tumor visualization. CONCLUSIONS: These preclinical findings identify GF as a candidate dual-action agent for GBM treatment. Whether the fluorescence enhancement translates into improved intraoperative detection, extent of resection, or patient survival remains to be determined through future in vivo and clinical studies.

Schlagwörter

Stichwörter der Autor:innen

5-aminolevulinic acidCancer stem cellsDrug repurposingGlioblastomaPhotodynamic diagnosis

Autor:innen und Institutionen

  • Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan; Department of Neurosurgery, Gifu University School of Medicine, Gifu, Japan.
  • Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan.
  • Department of Neurosurgery, Gifu University School of Medicine, Gifu, Japan.
  • Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu, 501-1196, Japan. Electronic address: shimazawa@gifu-pu.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nishiwaki, T., Yamada, T., Kudo, U., Nakamura, S., Kuse, Y., Shoda, K., Yamada, T., Takei, H., Egashira, Y., Hara, H., Nakayama, N., Izumo, T., & Shimazawa, M. (2026). Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells. Cancer Treatment and Research Communications, 49, 101433. https://doi.org/10.1016/j.ctarc.2026.101433

Vancouver

Nishiwaki T, Yamada T, Kudo U, Nakamura S, Kuse Y, Shoda K, et al. Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells. Cancer Treatment and Research Communications. 2026;49:101433. doi:10.1016/j.ctarc.2026.101433

BibTeX
@article{Nishiwaki2026,
  author = {Nishiwaki, Takayuki and Yamada, Takumi and Kudo, Urara and Nakamura, Shinsuke and Kuse, Yoshiki and Shoda, Kenji and Yamada, Tetsuya and Takei, Hiroaki and Egashira, Yusuke and Hara, Hideaki and Nakayama, Noriyuki and Izumo, Tsuyoshi and Shimazawa, Masamitsu},
  title = {Griseofulvin as a dual-action agent against glioblastoma: anti-tumor effect and enhancement of 5-ALA photodynamic diagnosis in stem-like cells},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101433},
  doi = {10.1016/j.ctarc.2026.101433}
}
Kostenlos starten →